SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-050488
Filing Date
2017-08-28
Accepted
2017-08-28 20:14:39
Documents
2
Period of Report
2017-08-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5976
2 POA DOCUMENT poa.txt EX-24.3_741906 3053
  Complete submission text file 0001209191-17-050488.txt   10542
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Issuer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HORIZON PHARMA, PLC ADELAIDE CHAMBERS, PETER STREET DUBLIN 8 L2 000000
Business Address
Mosbrooker Eric (Reporting) CIK: 0001715283 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35238 | Film No.: 171055888